Wednesday, July 8, 2026

pharma · Cystic Fibrosis (CF) · Accidental Hypothermia · SION

Sionna Therapeutics

Sionna Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Boston, USA HQ
2019 Founded
74 Employees
Public company Type
SION · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Founded
2019
Employees
74
Programs
5
Drugs
4
Patents
0
Intelligence · Clinical Programs

Sionna Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Sionna Therapeutics.

Sionna Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. SION-719

    Sionna Therapeutics

    Cystic Fibrosis (CF)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Sionna Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.